Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

about

Diagnostic approaches for diabetic cardiomyopathy.Hyperglycemia Determines Increased Specific MicroRNAs Levels in Sera and HDL of Acute Coronary Syndrome Patients and Stimulates MicroRNAs Production in Human Macrophages.

P2860

Q30362092-2FF4DC40-CCD7-4680-BA4C-2E0007D63961 Q36102976-E6219676-06F7-4B81-8462-025C34FB2CAA

P2860

Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

Item

http://www.wikidata.org/entity/Q38806467

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

@en

type

Item

label

Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

@en

prefLabel

Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

@en

P1476

Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

@en

P2093

Anne Pernille Ofstad

http://www.w3.org/2001/XMLSchema#string

P2860

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents

Strategies for multivessel revascularization in patients with diabetes

Diabetic and hypertensive heart disease

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus

Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review

Effects of intensive glucose lowering in type 2 diabetes

10-year follow-up of intensive glucose control in type 2 diabetes

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

P304

271-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/00365513.2016.1155230

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27071642

http://www.w3.org/2001/XMLSchema#string

Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

about

P2860

P2860

Myocardial dysfunction and cardiovascular disease in type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698